IVD Regulatory Update February 2015
|
|
- Milo Douglas
- 6 years ago
- Views:
Transcription
1 IVD Regulatory Update February 2015 Sue Spencer Head of IVD Notified Body Copyright 2015 BSI. All rights reserved.
2 Content IVD proposals Expected timelines Impacts: Re-classification Clinical evidence How can you prepare? Copyright 2015 BSI. All rights reserved. 2
3 On the move The IVD Directive has moved from Enterprise and Industry Many documents are on the move to the Growth part of the Commission website New harmonised standards list EN980 has been reinstated onto the harmonised standards list Copyright 2015 BSI. All rights reserved. 3
4 Timeline Regulations have direct entry into force upon publication No transposition period, as for a Directive Transition period currently being negotiated for 5 years for IVDs Additional implementing acts will be needed after the Regulation is published Implications for Manufacturers and Notified Bodies Guidance may not be issued until after the implementing acts have been published Copyright 2015 BSI. All rights reserved. 4
5 IVDR Timeline - Realistic expectation Greek Presidency Italian Presidency Latvian Presidency Council reaches general approach? Luxembourg Presidency Dutch Presidency Jan 2014 July 2014 Jan 2015 July 2015 Jan 2016 Parliament elections Parliament 1 st reading Rapporteurs appointed New Commissioners in place Begin trilogues? Conclude trilogues? Entry into force? Copyright 2015 BSI. All rights reserved. 5
6 Key Topics Scope and therefore the definitions The definition of an IVD will direct or indirect harm be included? Genetic tests Companion Diagnostics In-house exemptions what will the scope be, which classes of device and the extent of the Healthcare Institution Classification rules and associated conformity routes Clinical Evidence what are the expectations? device for genetic testing means an in vitro diagnostic medical device the purpose of which is to identify a genetic characteristic of a person which is inherited or acquired during prenatal development; Companion diagnostic means a device specifically intended for and essential to the selection of patients with a previously diagnosed condition or predisposition as suitable or unsuitable for a specific therapy with a medicinal product or a range of medicinal products; Copyright 2015 BSI. All rights reserved. 6
7 Classification Copyright 2015 BSI. All rights reserved. 7
8 Classification rules Draft IVDR rules have been based on the Global Harmonisation Task Force/GHTF rules (now found in IMDRF) Reference: Principles of IVD Medical Devices Classification SG1 Final Document GHTF/SG1/N045:2008 Already implemented by other IMDRF participating nations e.g. Australia and Canada (similar not identical) Copyright 2015 BSI. All rights reserved. 8
9 Classification rules Draft IVDR rules have been based on the Global Harmonisation Task Force/GHTF rules (now found in IMDRF) Reference: Principles of IVD Medical Devices Classification SG1 Final Document GHTF/SG1/N045:2008 Already implemented by other IMDRF participating nations e.g. Australia and Canada (similar not identical) Rules are based on overall risk to Individual patient risk Population risk Copyright 2015 BSI. All rights reserved. 9
10 1.1. Application of the classification rules shall be governed by the intended purpose, novelty, complexity and inherent risk of the devices. Copyright 2015 BSI. All rights reserved. 10
11 Conformity Routes for the IVDR Self Tests also have to meet the requirements in Annex VIII.6 Copyright 2015 BSI. All rights reserved. 11
12 Work in progress Preparations to move from Annex II List A devices future Class D Common Technical Specification (CTS) Contain performance evaluation criteria Prepared by an Expert Group of the Commission Manufacturers expected to comply with the CTS if it exists Work in progress CTS in draft: HIV self-test CTS in progress Chagas disease Syphilis Copyright 2015 BSI. All rights reserved. 12
13 Under discussion Special Notified Bodies being viewed as a means of the European Commission and Regulators having greater scrutiny on NBs doing highest risk certifications Notified Body Class B & Class C Copyright 2015 BSI. All rights reserved. 13
14 We are a growing team! IVD Directive Require a Notified Body Do not require a Notified Body 80-90% IVD Regulation Require a Notified Body 80-90% Do not require a Notified Body BSI IVD team Global span US, UK, Asia In-house expertise for all Annex II List A devices Copyright 2015 BSI. All rights reserved. 14
15 Clinical Evidence Copyright 2015 BSI. All rights reserved. 15
16 Clinical Evidence under the proposed IVDR Increased expectation for clinical requirements Based on IMDRF (GHTF) guidance GHTF/SG5/N6:2012 Clinical Evidence for IVD medical devices Key Definitions and Concepts. GHTF/SG5/N7: Clinical Evidence for IVD medical devices Scientific Validity Determination and Performance Evaluation. GHTF/SG5/N8: Clinical Evidence for IVD Medical Devices - Clinical Performance Studies for In Vitro Diagnostic Medical Devices. Copyright 2015 BSI. All rights reserved. 16
17 Updates Development of a standard related to clinical performance studies for IVDs ISO TC 212 WG3 Clinical performance studies for in vitro diagnostic medical devices (IVDs) using specimens from human subjects Good study practice. May be 5 years before publication New European requirements will be fully defined in an implementing act following IVDR publication Copyright 2015 BSI. All rights reserved. 17
18 Clinical Utility The usefulness of the results obtained from testing with the IVD medical device and the value of the information to the individual being tested and/or the broader population Clinical Utility has never been a regulatory requirement in Europe Clinical Utility is still under discussion but likely to be required for Companion Diagnostics Copyright 2015 BSI. All rights reserved. 18
19 Three pillars of clinical evidence Clinical evidence Scientific validity Refers to the association of an analyte to a clinical condition or physiological state Analytical performance Refers to the ability of an IVD medical device to correctly detect and measure a particular analyte Clinical performance Refers to its ability to yield results that relate to a particular clinical condition physiological state for the intended use and in accordance with target population and where applicable to the intended user For established analytes, this may be from literature; but for companion diagnostics or novel analytes this needs to be established Performance requirements similar to IVD Directive essential requirements Performance evaluation Data to support diagnostic accuracy compared to reference test; information related to expected values Copyright 2015 BSI. All rights reserved. 19
20 How can you start to prepare? Copyright 2015 BSI. All rights reserved. 20
21 Impact! Planning for future clinical evidence requirements NOW! Future requirements need to be put into planning and development Transition period vital Existing IVD devices need to be reviewed There is no grandfathering Existing technical files / technical documentation may need to be supplemented This will be dependent on the device, intended use and risk Clinical evidence may be reviewed by a NB under the new classification rules Copyright 2015 BSI. All rights reserved. 21
22 Preparation! How would your devices be classified under the proposed rules? Plan for your products/ product families How could products be grouped under certificate scopes? What conformity assessment routes would you take? Which first? Plan for technical file reviews Prioritise / sample QMS procedures Identify where new procedures will be needed or existing procedures may need to change Copyright 2015 BSI. All rights reserved. 22
23 Preparation! Talk to your Notified Body! Copyright 2015 BSI. All rights reserved. 23
24 New BSI courses to help with the transition Performance Evaluation and clinical evidence for IVDs Technical Files and Design Dossiers for IVDs US event: San Diego, 3, 4 & 5 March Preparing for the IVD Regulation Copyright 2015 BSI. All rights reserved. 24
25 Questions Copyright 2015 BSI. All rights reserved. 25
26 Contacts Name: Sue Spencer Head of IVD Mobile: +44 (0) Website: Address: BSI Kitemark Court Davy Avenue Milton Keynes MK5 8PP UK Copyright 2015 BSI. All rights reserved. 26
European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals
European IVD Regulations and Risk Based Classification An Overview for Global Quality Professionals Anna Sadio IVD Technical Expert/Project Manager Oct 2013 Caution The new regulations are draft and subject
More informationIMDRF Project: List of international standards recognized by IMDRF management committee members
List of international standards recognized by IMDRF management committee members Progress Report Dr. Matthias Neumann Federal Ministry of Health Germany matthias.neumann@bmg.bund.de Sydney, 25.9.2012 Mandate:
More informationIVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices. Med-Info. TÜV SÜD Product Service GmbH
Med-Info International expert information for the Medical Device industry IVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices The current regulatory framework
More informationChanges in the Medical Device Legislation; the day after. Jan Bart Hak 1
PPN Najaarsbijeenkomst 21 November 2017 Changes in the Medical Device Legislation; the day after. How much time do we have left? Jan Bart Hak Jan Bart Hak 1 Company Leading consultancy and project management
More informationNew EU legislation on Medical Devices. Erik Hansson Deputy Head of Unit European Commission DG Health and Consumers 1
New EU legislation on Medical Devices Erik Hansson Deputy Head of Unit European Commission DG Health and Consumers 1 Drivers for change Presentation Commission proposals State of play in negotiations What
More informationInternational Trend on Medical Device Regulatory Convergence
International Trend on Medical Device Regulatory Convergence 5th Joint Conference of Taiwan and Japan on Medical Products Regulation December 1, 2017 Taipei 1 Content Overview of major international harmonization
More informationIntroduction of Saudi Arabia Medical Device Regulatory System Ali Al Dalaan Executive Director, SFDA AHWP TC Chair
Introduction of Saudi Arabia Medical Device Regulatory System Ali Al Dalaan Executive Director, SFDA AHWP TC Chair IMDRF Meeting. 20-22 March,2018. Shanghai, China Saudi Food & Drug Authority ) Drug Food
More informationGuide to Incident Reporting for In-vitro Diagnostic Medical Devices
Guide to Incident Reporting for In-vitro Diagnostic Medical Devices SUR-G0004-4 02 AUGUST 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
More informationIntroduction of AHWP. IMDRF Stakeholder Meeting 25 March 2015
Introduction of AHWP IMDRF Stakeholder Meeting 25 March 2015 Introduction of AHWP Contents Goals Strategic Framework Organization structure of AHWP Newly elected AHWP and AHWP TC Leaders for the term 2015
More informationAustralian Standard. Clinical investigations of medical devices for human subjects. Part 1: General requirements AS ISO ISO :2003
AS ISO 14155.1 2004 ISO 14155-1:2003 AS ISO 14155.1 2004 Australian Standard Clinical investigations of medical devices for human subjects Part 1: General requirements This Australian Standard was prepared
More informationFINAL DOCUMENT. Global Harmonization Task Force
GHTF/SG5/N5:2012 FINAL DOCUMENT Global Harmonization Task Force Title: Reportable Events During Pre-Market Clinical Investigations Authoring Group: Study Group 5 of the Global Harmonization Task Force
More informationTopic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015
Topic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015 1. What are the CAP s views on the regulatory oversight of laboratory-developed tests (LDTs)? 2. How are
More informationDesignation of Australian conformity assessment bodies for medical devices Implementation, Version 1.0, November 2016
Designation of Australian conformity assessment bodies for medical devices, Version 1.0, November 2016 To: Business Improvement and Support Section Medical Devices Branch Therapeutic Goods Administration
More informationRaad voor Accreditatie (Dutch Accreditation Council RvA) Specific Accreditation Protocol for Certification according to ISO/IEC 13485
Raad voor Accreditatie (Dutch Accreditation Council RvA) Specific Accreditation Protocol for Certification according to ISO/IEC 13485 Document code: RvA-SAP-C021-UK Version 2, 6-6-2017 A Specif ic Accreditation
More informationGreek-German Cooperation for Research and Innovation. Theodore Tryfon Co-CEO ELPEN Group President, PanHellenic Union Of Pharmaceutical Industries
Greek-German Cooperation for Research and Innovation Theodore Tryfon Co-CEO ELPEN Group President, PanHellenic Union Of Pharmaceutical Industries Greek Pharmaceutical Industry and Economy 27 hi-end production
More informationExpert Review Panel for Diagnostics - Lessons Learnt
Expert Review Panel for Diagnostics - Lessons Learnt Dr. Mariatou Tala Jallow, Head, Sourcing and Procurement of Health Products November 2015 Copenhagen What is the Expert Review Panel for Diagnostics
More informationIAF Mandatory Document for the Application of ISO/IEC in Medical Device Quality Management Systems (ISO 13485)
IAF MD 8:2011. International Accreditation Forum, Inc.(IAF) IAF Mandatory Document IAF Mandatory Document for the Application of ISO/IEC 17011 in Medical Device Quality Management Systems (ISO (IAF MD
More informationBrussels, 12 June 2014 COUNCIL OF THE EUROPEAN UNION 10855/14. Interinstitutional File: 2012/0266 (COD) 2012/0267 (COD)
COUNCIL OF THE EUROPEAN UNION Brussels, 12 June 2014 Interinstitutional File: 2012/0266 (COD) 2012/0267 (COD) 10855/14 PHARM 44 SAN 232 MI 492 COMPET 405 CODEC 1471 NOTE from: General Secretariat of the
More informationProcedure for handling applications for authorisation and review reports under REACH
Procedure for handling applications for authorisation and review reports under REACH 1. Purpose This procedure describes how to handle applications for authorisation (AfA) as established by the REACH Regulation
More informationFinal Draft Agenda Sixteenth meeting of the Forum for Exchange of Information on Enforcement (Forum-16) October 2013
18 October 2013 ECHA/Forum-16/2013/A/final Final Draft Agenda Sixteenth meeting of the Forum for Exchange of Information on Enforcement (Forum-16) 28-31 October 2013 European Chemicals Agency Helsinki,
More informationEducation and Training Committee, 5 June 2014
Education and Training Committee, 5 June 2014 Directive 2013/55/EU the revised Recognition of Professional Qualifications (RPQ) Directive challenges and opportunities for the Health and Care Professions
More informationPost Market Surveillance (PMS): National Competent Authority Report (NCAR) Exchange Programme under IMDRF
Post Market Surveillance (PMS): National Competent Authority Report (NCAR) Exchange Programme under IMDRF SAMED Conference, 2-3/12/2015 Dr Isabelle Demade What is IMDRF? Introduction - established in 2011
More informationInternational trend on medical device regulatory convergence
International trend on medical device regulatory convergence Mari Shirotani, Ph.D. Division Director, Office of International Programs Pharmaceuticals and Medical Devices Agency (PMDA) 1st December, 2017
More informationCLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success
CLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success Jack Zakowski, PhD, FACB Director, Scientific Affairs and Professional Relations
More informationEFLM EUROPEAN FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE
EFLM EUROPEAN FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE EFLM connects National Societies of Clinical Chemistry and Laboratory Medicine and creates a platform for all European Specialists
More informationMSc REGULATORY AFFAIRS MEDICINES / MEDICAL DEVICES PROSPECTUS
MSc REGULATORY AFFAIRS MEDICINES / MEDICAL DEVICES PROSPECTUS ABOUT THE MSc ABOUT US The Organisation for Professionals in Regulatory Affairs has been running the TOPRA MSc Regulatory Affairs more than
More informationCouncil, 25 September 2014
Council, 25 September 2014 Directive 2013/55/EU the revised Recognition of Professional Qualifications (RPQ) Directive challenges and opportunities for the Health and Care Professions Council (HCPC) Executive
More informationIMDRF FINAL DOCUMENT. Title: Strategic Assessment of Electronic Submission Messaging Formats
IMDRF International Medical Device Regulators Forum FINAL DOCUMENT International Medical Device Regulators Forum Title: Strategic Assessment of Electronic Submission Messaging Formats Authoring Group:
More informationEUROPEAN PARLIAMENT Committee on the Environment, Public Health and Food Safety
EUROPEAN PARLIAMT 2009-2014 Committee on the Environment, Public Health and Food Safety 2012/0266(COD) 12.4.2013 ***I DRAFT REPORT on the proposal for a regulation of the European Parliament and of the
More informationDRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy
European Parliament 2014-2019 Committee on Industry, Research and Energy 2018/0018(COD) 13.4.2018 DRAFT OPINION of the Committee on Industry, Research and Energy for the Committee on the Environment, Public
More informationSUMMARY REPORT OF THE 17 th ACCSQ MDPWG MEETING
SUMMARY REPORT OF THE 17 th ACCSQ MDPWG MEETING INTRODUCTION 1) The 17 th Meeting of the Medical Device Product Working Group (MDPWG) was held on 25-26 April 2013 in Petaling Jaya, Malaysia. The Meeting
More informationRegulatory Updates Health Sciences Authority Singapore
Regulatory Updates Health Sciences Authority Singapore Wong Woei Jiuang Director, Medical Devices Branch, Health Sciences Authority, Singapore Background Scope Pre-market Consultation (PMC) Scheme Medical
More informationPresident s report THIRD EFCC GENERAL ASSEMBLY 17 APRIL 2010, CORFU, GREECE.
President s report THIRD EFCC GENERAL ASSEMBLY 17 APRIL 2010, CORFU, GREECE Goals of EFCC Promotion of science and education within CCLM Improve patient outcomes and the quality and safety of patient care
More informationGuidance on the preparation of dossiers for harmonised classification and labelling (CLH) under Regulation (EC) No.
Guidance on the preparation of dossiers for harmonised classification and labelling (CLH) under Regulation (EC) No. 1272/2008 DRAFT LEGAL NOTICE This document contains guidance to the preparation of dossiers
More informationMedical Device and Health Software
Medical Device and Health Software Standards and regulations now and in the future Justin McCarthy Introduction I was head of Clinical Engineering in Cardiff till 2009. I have been chair of BSI committee
More informationPost Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015
Post Market Surveillance Requirements SAMED Regulatory Conference 2 December 2015 Topics Surveillance & Vigilance Adverse Events Reportable Adverse Events Reporting Adverse Events Time frames Exemptions
More informationASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014
Management Board Decision 07/2015 1(5) ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014 THE MANAGEMENT BOARD, Having regard to Regulation (EC) No 1907/2006
More informationInternational Medical Device Regulatory Harmonization. Reality or Fantasy?
International Medical Device Regulatory Harmonization Reality or Fantasy? Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Harvard University; 28-30 March 2007 M. Gropp; Medtronic,
More informationGUIDELINES ON A MEDICAL DEVICES VIGILANCE SYSTEM
EUROPEAN COMMISSION DG ENTERPRISE AND INDUSTRY Directorate F-Consumer Good Unit F3- Cosmetic and Medical Devices MEDICAL DEVICES: Guidance document MEDDEV 2.12-1 rev 6 December 2009 GUIDELINES ON A MEDICAL
More informationEuropean CE Marking of Medical Devices. October 2017
European CE Marking of Medical Devices October 2017 1 2017 EU Regulations Why? Response to scandals to restore confidence in system Keep pace with scientific and technical developments Overcome divergence
More informationRegulatory Control of Diagnostics in Tanzania. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority
6 th Consultative Stakeholders Meeting on UN PQ of Medicines, Diagnostics and Vaccines 4-5 April, 2011, Geneva, Switzerland Regulatory Control of Diagnostics in Tanzania Hiiti Sillo Ag. Director General
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationEVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationImproving the quality of diagnostic spirometry in adults: the National Register of certified professionals and operators
Improving the quality of diagnostic spirometry in adults: the National Register of certified professionals and operators September 2016 Improving the quality of diagnostic spirometry in adults: the National
More informationNewborn Screening Programmes in the United Kingdom
Newborn Screening Programmes in the United Kingdom This paper has been developed to increase awareness with Ministers, Members of Parliament and the Department of Health of the issues surrounding the serious
More informationAdopted by Pharmacovigilance Risk Assessment Committee 20 February Adopted by Pharmacovigilance Inspectors Working Group 21 March 2014
21 March 2014 EMA/INS/PhV/192231/2014 Union procedure on the management of pharmacovigilance inspection findings which may impact the robustness of the benefit-risk profile of the concerned medicinal Adopted
More informationFINAL STATUS DOCUMENT
GHTF/SG2/N68R3: 2005 FINAL STATUS DOCUMENT Global Harmonization Task Force Title: Summary of Current Requirements for Where to Send Adverse Event Reports. Authoring Group: GHTF Study Group 2 Endorsed by:
More informationHygienic Management of Medical Devices in/for Health Care Facilities. The Austrian Way. Wolfgang Ecker Fed. Min. of Health, Family and Youth
Hygienic Management of Medical Devices in/for Health Care Facilities The Austrian Way May 3 rd 2007, Baden Wolfgang Ecker Fed. Min. of Health, Family and Youth EU Medical Device - Directives Directive
More informationMedical devices briefing for patients: Patient safety in the new Regulation
Medical devices briefing for patients: Patient safety in the new Regulation 20/12/2016 Patient safety is an important priority for the European Patients Forum, and it was also our main priority in our
More informationBest Practices for Equipment Calibration and Analytical Controls in the Diagnostics Laboratory
Best Practices for Equipment Calibration and Analytical Controls in the Diagnostics Laboratory George Rodrigues, Artel (slides 2-16) Rebecca Butler, CareDx (slides 17-29) Agenda Agenda Theory / Regulations
More informationGuide to Incident Reporting for General Medical Devices and Active Implantable Medical Devices
Guide to Incident Reporting for General Medical Devices and Active Implantable Medical Devices SUR-G0003-4 09 JULY 2012 This guide does not purport to be an interpretation of law and/or regulations and
More informationImplementation of REACH & CLP: common challenges of national authorities and ECHA
Implementation of REACH & CLP: common challenges of national authorities and ECHA Finnish Safety and Chemicals Agency (Tukes); Opening Seminar 9 February 2011, Tampere Geert Dancet Executive Director Content
More informationFundamentals in Regulatory Affairs for Medical Technologies
Fundamentals in Regulatory Affairs for Medical Technologies Developed by Industry for Industry NFQ Level 8 9 ects The Irish Medtech Skillnet is funded by member companies and the Training Networks Programme,
More informationThe CLSI Consensus Process: Making a Difference in Health Care David Sterry, MT(ASCP) Director, Standards Development, CLSI
The CLSI Consensus Process: Making a Difference in Health Care David Sterry, MT(ASCP) Director, Standards Development, CLSI Today s Topics and Goals Introduction to CLSI The consensus process: a primer
More informationQuestions and answers on the procedure of PIP compliance verification at EMA, and on paediatric rewards
15 December 2014 EMA/PDCO/179892/2011 Rev. 2 Product Development Scientific Support Paediatric Medicines Questions and answers on the procedure of PIP compliance verification at EMA, and on paediatric
More informationAddendum to ICH E6 (R2)
Addendum to ICH E6 (R2) Stephanie Shapley (US FDA) - Rapporteur Dr. Fergus Sweeney (EMA) - Regulatory Chair Date: December 15, 2015 International Council for Harmonisation of Technical Requirements for
More informationGuidance on Quality Management in Laboratories
Guidance on Quality Management in Laboratories series QULAITY IBMS 1 Institute of Biomedical Science Guidance on Quality Management in Laboratories As the UK professional body for biomedical science the
More information...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS
...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS 1 Table of Contents Pg 3 Pg 4 Pg 5 About Ivowen Limited Meet the team Pharmaceutical Regulatory Affairs Services: Human & Veterinary Pg 5 Pg 5 National Procedures
More informationWhich QMS Standard should be chosen for the structural quality of a medical laboratory? Matthias ORTH
Which QMS Standard should be chosen for the structural quality of a medical laboratory? Matthias ORTH IFCC Committee on Clinical Laboratory Management - http://www.ifcc.org/ifcc-education-division/emd-committees/c-clm/
More informationICH Topic Q4B Annex 6 Uniformity of Dosage Units General Chapter. Step 3
European Medicines Agency December 2008 EMEA/CHMP/ICH/645408/2008 ICH Topic Q4B Annex 6 Uniformity of Dosage Units General Chapter Step 3 ANNEX 6 TO NOTE FOR EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More information9/10/2013. Contributions of ECHA to the achievement of the REACH goals. Content of Discussion
Contributions of ECHA to the achievement of the REACH goals 5 Jahre REACH und weitere Beitrage zur Nachhaltigen Chemie Darmstadt, Germany 4 September 2013 Geert Dancet Executive Director Content of Discussion
More informationCommission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo
Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics 30.1.2017 Oslo 3.2.2017 O. Konttinen 1 Background Based on directive 2001/20/EC of the clinical trials on medicinal
More informationMDUFA Performance Goals and Procedures Process Improvements Pre-Submissions Submission Acceptance Criteria Interactive Review
Page 1 MDUFA Performance Goals and Procedures... 3 I. Process Improvements... 3 A. Pre-Submissions... 3 B. Submission Acceptance Criteria... 4 C. Interactive Review... 5 D. Guidance Document Development...
More informationImplementation of the new pharmacovigilance legislation: Overall update and activities in 2013
Implementation of the new pharmacovigilance legislation: Overall update and activities in 2013 Workshop for micro, small and medium-sized enterprises (SMEs) European Medicines Agency (EMA), London 26 April
More informationSoftware Regulation and Validation
Software Regulation and Validation Keiichiro Ozawa FUJIFILM Corporation 12/07/2016 4th Joint Conference of Taiwan and Japan on Medical Products Regulation 1 Agenda 0. Introduction 1. Qualification and
More informationThe Future is Now: Global Application of CLSI and ISO:15189 Quality Management Systems
The Future is Now: Global Application of CLSI and ISO:15189 Quality Management Systems Executive War College May 5, 2009 Glen Fine, MS, MBA Executive Vice President, CLSI Key Discussion Points Upon completion
More informationBackground to CLP. Presentation Overview. Why Introduce GHS? Basic CLP requirements 8/30/2011
About the Speaker Classifications, Labeling & Packaging (CLP) Regulatory Compliance AHMP National Conference August 29, 2011 Isaac Powell Product Manager - Technical Services 3E Company Carlsbad, CA Isaac
More informationClinical and Laboratory Standards Institute: Addressing POCT Needs; The Good, The Bad, and The Risky
Clinical and Laboratory Standards Institute: Addressing POCT Needs; The Good, The Bad, and The Risky Marcy Anderson MS, MT(ASCP) Director, Education 3 Rivers POCT Network June 7, 2012 Today s Presentation
More informationFact Sheet How to manage IP in FP7 during and after the project
European IPR Helpdesk Fact Sheet How to manage IP in FP7 during and after the project April 2014 1 Introduction... 1 1. Implementation stage... 2 1.1 Knowledge management bodies... 2 1.2 Results ownership...
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 8.7.2016 COM(2016) 449 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on implementation of Regulation (EC) No 453/2008 of the European Parliament
More informationNBOG Report for the period
NBOG Report for the period 2005 2008 1 Introduction...2 2 Background...2 3 Work Programme, Activities, Achievements...2 3.1 Overview...2 3.2 Guidance documents...3 3.3 Review of NB-MED Recommendations...6
More informationECF lobby for cycling: 10 key issues for the years 2009 and 2010
ECF lobby for : 10 key issues for the years 2009 and 2010 ECF is committed to the lobbying plan submitted by ECF and ETRA to the SRAM Cycling Fund on 13 March 2009. ECF submits now a version of that plan
More informationApril 21 st, 2016 Webinar. registrations What is next for the industry?
April 21 st, 2016 Webinar A look beyond REACH 2018 registrations What is next for the industry? Some Notes It is assumed that attendees have basic knowledge about REACH. Let us make this webinar interactive,
More informationEU Poison Centres Webinar. 27 May 2014, 9:00am BST
EU Poison Centres Webinar 27 May 2014, 9:00am BST Today s webinar aims v To hear about the current state of play on the changes that are likely to be proposed on the reporting of information to EU poison
More informationDecontamination of Medical Devices:
Decontamination of Medical Devices: a development plan for healthcare organisations January 2016 Crown copyright 2016 WG27312 Digital ISBN 978 1 4734 5431 6 Foreword Eliminating preventable healthcare
More informationCMDv/BPG/002. BEST PRACTICE GUIDE for Veterinary Decentralised Procedure (DCP)
BEST PRACTICE GUIDE for Veterinary Decentralised Procedure (DCP) Edition number: 05 Edition date: 7 November 2013 Implementation date: 6 February 2006 CMDv Secretariat: 7 Westferry Circus, Canary Wharf,
More informationFeedback on SADC Workshop of Industry & Regulators. Luther Gwaza PhD Consultant
Feedback on SADC Workshop of Industry & Regulators Luther Gwaza PhD Consultant SADC WORKSHOP ON REGISTRATION OF MEDICINES & GOOD MANUFACTURING PRACTICE STANDARDS 11 TH 13 TH APRIL 2016, SOUTH AFRICA Brief
More informationStandards for pre-registration nursing programmes
Part 3: Programme standards Standards for pre-registration nursing programmes Introduction Our Standards for pre-registration nursing programmes set out the legal requirements, entry requirements, availability
More informationCLP the implementation of GHS in the EU Facts and practical advice
CLP the implementation of GHS in the EU Facts and practical advice Seminar on the latest trend regarding revised CSCL, REACH and CLP 30 March 2010, Tokyo Gabriele Schöning ECHA Classification Unit Content
More informationUpdate on FDA-EMA QbD Pilot
Update on FDA-EMA QbD Pilot Presented by: Sharmista Chatterjee, PhD Branch Chief (Acting) Office of Process & Facility Office of Pharmaceutical Quality CDER, FDA Dolores Hernán, PhD Quality Office Specialized
More informationQuality assurance in medical laboratories
Quality & Safety Laboratory medicine Quality assurance in medical laboratories Paths to global competence standards Prof. Dr. Egon Amann Hamm-Lippstadt University of Applied Sciences, Germany 50 www.q-more.com/en/
More informationSAMPLE. Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions
4th Edition C24 Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions This guideline provides definitions, principles, and approaches to laboratory quality control
More informationCOMMERCIALISATION FUND PROGRAMME Reference Document
COMMERCIALISATION FUND PROGRAMME Reference Document PROGRAMME OVERVIEW The aim of the Commercialisation Fund programme is to improve the competitiveness of the Irish economy through the creation of technology
More informationBrokerage for the first ProSafe Call Dina Carrilho Call Secretariat Foundation for Science and Technology (FCT), Portugal
Brokerage for the first ProSafe Call Dina Carrilho Call Secretariat ProSafe@fct.pt Foundation for Science and Technology (FCT), Portugal ProSafe is offering two main opportunities for the implementation
More informationCALL FICHE 1 SCIENCE IN SOCIETY 2009
CALL FICHE 1 SCIENCE IN SOCIETY 2009 Call identifier: FP7-SCIENCE-IN-SOCIETY-2009-1 Date of publication: Wednesday 3 September 2008 Deadline: Tuesday 13 January 2009 at 17.00.00, Brussels local time. Indicative
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Corrective and Preventative Action SOP-QMS-008 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s)
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationGuidance for applicants requesting scientific advice
7 December 2017 EMEA/CVMP/SAWP/172329/2004 Rev. 5 Veterinary Medicines Division Introduction The Scientific Advice Working Party (SAWP-V) of the Committee for Medicinal Products for Veterinary Use (CVMP)
More informationPractical guide 7: How to notify substances in the Classification and Labelling Inventory
Practical guide 7: How to notify substances in the Classification and Labelling Inventory LEGAL NOTICE This document contains guidance on the CLP Regulation explaining the CLP obligations and how to fulfil
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Inhealth Diagnostic Centre 688 South Fifth Street, Milton Keynes,
More informationCOMMISSION DIRECTIVE 2011/18/EU
2.3.2011 Official Journal of the European Union L 57/21 DIRECTIVES COMMISSION DIRECTIVE 2011/18/EU of 1 March 2011 amending Annexes II, V and VI to Directive 2008/57/EC of the European Parliament and of
More informationOverview on diabetes policy frameworks in the European Union and in other European countries
Overview on policy frameworks in the European Union and in other European countries Countries plan Guidelines Belgium Guidelines for good medical practice type 2 The Belgian is limited to newly diagnosed
More informationJOB DESCRIPTION. Clinical Scientist. Molecular Genetics, Genetics Centre. Molecular Genetics, Genetics Centre, Viapath, Guy s Hospital
JOB DESCRIPTION JOB TITLE: Clinical Scientist GRADE: Band 7 DEPARTMENT: LOCATION: RESPONSIBLE TO: Molecular Genetics, Genetics Centre Molecular Genetics, Genetics Centre, Viapath, Guy s Hospital Molecular
More informationCall title: "The Ocean of Tomorrow 2013"
Call title: "The Ocean of Tomorrow 2013" Call identifier: FP7-OCEAN-2013 Date of publication: 10 July 2012 Deadline: 07 February 2013 at 17.00.00, Brussels local time 1 Indicative budget 2 : EUR 55 million
More informationStandard operating procedure
Standard operating procedure Title: Evaluation procedure for applications and requests for the establishment or review of Maximum Residue Limits (MRLs) Status: PUBLIC Document no.: SOP/V/4150 Lead author
More informationA Comparison of Nursing and Engineering Undergraduate Education
A Comparison of Nursing and Engineering Undergraduate Education Melanie Gauci*,Ann Perz**, Senay Purzer*, Jane Kirkpatrick**, and Sara McComb* & ** *College of Engineering **School of Nursing Purdue University,
More informationLaw on Medical Devices
Law on Medical Devices The Law is published in the Official Gazette of the Republic of Montenegro, no. 79/2004 on 23.12.2004. I GENERAL PROVISIONS Article 1 Manufacturing and distribution of medical devices
More informationAnnex. Provisions on auditing notified conformity assessment bodies in the framework of Article 34 3 of the Agency Regulation 1
Making the railway system work better for society. in the framework of Article 34 3 of the Agency Regulation 1 1. Introduction This details the audits performed by the Agency in the framework of the monitoring
More information